Cancer Genetics Inc (NASDAQ:CGIX)

1.75
Delayed Data
As of Feb 21
 -0.05 / -2.78%
Today’s Change
1.55
Today|||52-Week Range
5.30
-5.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash9.5M9.7M6.2M4.8M
 
 
 
 
 
Short Term Investment Cash-1.2M162.0K-3.5M-1.4M
 
 
 
 
 
Cash & Short Term Investments9.5M9.7M6.2M4.8M
 
 
 
 
 
 
ReceivablesReceivables11.7M12.7M13.2M15.8M
 
 
 
 
 
 
InventoriesInventories146.0K0.000.000.00
 
 
 
Current AssetsPrepaid Expenses2.0M------
 
 
Other Current Assets--2.0M2.5M2.9M
 
 
 
 
Current Assets23.4M24.4M21.9M23.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross11.1M------
 
 
Depreciation-6.4M------
 
 
Intangible Assets13.5M13.5M13.4M22.5M
 
 
 
 
 
Other Assets13.7M13.7M13.8M23.9M
 
 
 
 
 
Total Assets42.4M43.4M40.9M54.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable8.1M8.1M6.7M9.0M
 
 
 
 
 
Short Term Debt2.1M229.0K2.3M2.3M
 
 
 
 
 
Accrued Expenses------345.0K
 
 
Other Current Liabilities789.0K432.0K133.0K454.0K
 
 
 
 
 
Other Liabilities11.0M8.8M9.1M11.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.0M5.4M5.5M5.7M
 
 
 
 
 
Other Liabilities2.3M7.8M7.3M4.3M
 
 
 
 
 
Total Liabilities16.8M22.4M22.3M22.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity25.6M20.9M18.6M31.1M
 
 
 
 
 
Total Shareholder Equity25.6M20.9M18.6M31.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding18.9M19.8M19.8M24.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.